S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

Clinical trial NCT00075686 · COMPLETED

Trial details

NCT number: NCT00075686
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2004-01-01
Primary completion: 2007-05-01
Enrollment: 766

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.